JP2009533367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533367A5 JP2009533367A5 JP2009504628A JP2009504628A JP2009533367A5 JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5 JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody according
- amount
- less
- acc2795
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 4
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 claims 2
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 claims 2
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 claims 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims 1
- 102000038455 IGF Type 1 Receptor Human genes 0.000 claims 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000002254 cytotoxic agent Substances 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06007571 | 2006-04-11 | ||
| EP06007571.0 | 2006-04-11 | ||
| PCT/EP2007/003165 WO2007115814A2 (en) | 2006-04-11 | 2007-04-10 | Antibodies against insulin-like growth factor i receptor and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009533367A JP2009533367A (ja) | 2009-09-17 |
| JP2009533367A5 true JP2009533367A5 (enExample) | 2010-11-11 |
| JP4718634B2 JP4718634B2 (ja) | 2011-07-06 |
Family
ID=36940705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504628A Active JP4718634B2 (ja) | 2006-04-11 | 2007-04-10 | インスリン様増殖因子i受容体及びその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20080014203A1 (enExample) |
| EP (2) | EP2007810B1 (enExample) |
| JP (1) | JP4718634B2 (enExample) |
| KR (2) | KR101276513B1 (enExample) |
| CN (1) | CN101421305B (enExample) |
| AR (1) | AR060592A1 (enExample) |
| AU (1) | AU2007236199B2 (enExample) |
| BR (1) | BRPI0710185B8 (enExample) |
| CA (2) | CA2647181C (enExample) |
| CR (1) | CR10301A (enExample) |
| EC (1) | ECSP088816A (enExample) |
| ES (1) | ES2403075T3 (enExample) |
| IL (1) | IL194397A (enExample) |
| MX (1) | MX2008012950A (enExample) |
| NO (1) | NO20084082L (enExample) |
| NZ (1) | NZ571414A (enExample) |
| RU (1) | RU2541765C2 (enExample) |
| UA (1) | UA95284C2 (enExample) |
| WO (1) | WO2007115814A2 (enExample) |
| ZA (1) | ZA200808597B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7846724B2 (en) * | 2006-04-11 | 2010-12-07 | Hoffmann-La Roche Inc. | Method for selecting CHO cell for production of glycosylated antibodies |
| AR064464A1 (es) * | 2006-12-22 | 2009-04-01 | Genentech Inc | Anticuerpos anti - receptor del factor de crecimiento insulinico |
| PE20090368A1 (es) | 2007-06-19 | 2009-04-28 | Boehringer Ingelheim Int | Anticuerpos anti-igf |
| CA2709029A1 (en) | 2007-12-21 | 2009-07-02 | Bianca Eser | Stability testing of antibodies |
| CN103396487A (zh) | 2008-12-12 | 2013-11-20 | 贝林格尔.英格海姆国际有限公司 | 抗igf抗体 |
| WO2010112194A1 (en) * | 2009-04-02 | 2010-10-07 | F. Hoffmann-La Roche Ag | Antigen-binding polypeptides and multispecific antibodies comprising them |
| WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
| KR20120031083A (ko) | 2009-07-24 | 2012-03-29 | 에프. 호프만-라 로슈 아게 | 교반기 시스템 |
| WO2011044336A2 (en) * | 2009-10-07 | 2011-04-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| HUE033758T2 (en) | 2009-10-26 | 2017-12-28 | Hoffmann La Roche | A method for producing glycosylated immunoglobulin |
| US20110200595A1 (en) | 2010-02-18 | 2011-08-18 | Roche Glycart | TREATMENT WITH A HUMANIZED IgG CLASS ANTI EGFR ANTIBODY AND AN ANTIBODY AGAINST INSULIN LIKE GROWTH FACTOR 1 RECEPTOR |
| WO2011135040A1 (en) | 2010-04-30 | 2011-11-03 | F. Hoffmann-La Roche Ag | Fluorescent antibody fusion protein, its production and use |
| JP5947802B2 (ja) | 2010-11-05 | 2016-07-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ミックスモードクロマトグラフィーによる抗体捕捉の最適化方法 |
| ES2667864T3 (es) | 2011-06-22 | 2018-05-14 | F. Hoffmann-La Roche Ag | Eliminación de células diana mediante linfocitos T citotóxicos específicos de virus en circulación usando complejos que comprenden MHC de clase I |
| RU2502798C2 (ru) * | 2012-02-22 | 2013-12-27 | Общество с ограниченной ответственностью "Фармако Биотех" | КЛЕТОЧНАЯ ЛИНИЯ huFSHIK, СЕКРЕТИРУЮЩАЯ РЕКОМБИНАНТНЫЙ ЧЕЛОВЕЧЕСКИЙ ФСГ |
| EP2727941A1 (en) | 2012-11-05 | 2014-05-07 | MAB Discovery GmbH | Method for the production of multispecific antibodies |
| EP2914629A1 (en) | 2012-11-05 | 2015-09-09 | MAB Discovery GmbH | Method for the production of multispecific antibodies |
| RU2015129640A (ru) | 2012-12-21 | 2017-01-26 | Ф.Хоффманн-Ля Рош Аг | Связанные дисульфидом мультивалентные многофункциональные белки, содержащие молекулы гкгс класса 1 |
| US20140255413A1 (en) | 2013-03-07 | 2014-09-11 | Boehringer Ingelheim International Gmbh | Combination therapy for neoplasia treatment |
| WO2021119234A1 (en) * | 2019-12-10 | 2021-06-17 | Horizon Pharma Ireland Ltd. | Glycosylated antibodies against insulin-like growth factor i receptor and uses thereof |
| JP2023545520A (ja) | 2020-10-14 | 2023-10-30 | ビリジアン セラピューティクス, インコーポレイテッド | 甲状腺眼疾患を治療するための組成物及び方法 |
| WO2023019171A1 (en) | 2021-08-10 | 2023-02-16 | Viridian Therapeutics, Inc. | Compositions, doses, and methods for treatment of thyroid eye disease |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| US5202238A (en) * | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5204244A (en) * | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| GB9022543D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
| US5610297A (en) * | 1991-12-27 | 1997-03-11 | Georgia Tech Research Corp. | Peptides ketoamides |
| ES2091684T3 (es) | 1992-11-13 | 1996-11-01 | Idec Pharma Corp | Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b. |
| CA2369292C (en) * | 1999-04-09 | 2010-09-21 | Kyowa Hakko Kogyo Co. Ltd. | Method of modulating the activity of functional immune molecules |
| US20030165502A1 (en) * | 2000-06-13 | 2003-09-04 | City Of Hope | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
| US7241444B2 (en) * | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
| US7553485B2 (en) * | 2002-01-18 | 2009-06-30 | Pierre Fabre Medicament | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| EP2316922B1 (en) * | 2002-05-24 | 2013-05-22 | Merck Sharp & Dohme Corp. | Neutralizing human anti-IGFR antibody |
| JP4473257B2 (ja) * | 2003-04-02 | 2010-06-02 | エフ.ホフマン−ラ ロシュ アーゲー | インスリン様成長因子i受容体に対する抗体及びその使用 |
| AR046071A1 (es) * | 2003-07-10 | 2005-11-23 | Hoffmann La Roche | Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos |
| EP1666501A4 (en) * | 2003-08-11 | 2008-12-24 | Chugai Pharmaceutical Co Ltd | ANTI-HM1.24 ANTIBODIES WITH MODIFIED SUGAR CHAIN |
| WO2005034994A1 (ja) * | 2003-10-10 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | 固形腫瘍治療剤 |
-
2007
- 2007-04-05 US US11/784,029 patent/US20080014203A1/en not_active Abandoned
- 2007-04-10 NZ NZ571414A patent/NZ571414A/en not_active IP Right Cessation
- 2007-04-10 MX MX2008012950A patent/MX2008012950A/es active IP Right Grant
- 2007-04-10 CN CN2007800128287A patent/CN101421305B/zh active Active
- 2007-04-10 BR BRPI0710185A patent/BRPI0710185B8/pt active IP Right Grant
- 2007-04-10 ES ES07724106T patent/ES2403075T3/es active Active
- 2007-04-10 EP EP07724106A patent/EP2007810B1/en active Active
- 2007-04-10 KR KR1020087024802A patent/KR101276513B1/ko active Active
- 2007-04-10 CA CA2647181A patent/CA2647181C/en active Active
- 2007-04-10 WO PCT/EP2007/003165 patent/WO2007115814A2/en not_active Ceased
- 2007-04-10 UA UAA200812606A patent/UA95284C2/ru unknown
- 2007-04-10 EP EP10180713A patent/EP2363417A1/en not_active Withdrawn
- 2007-04-10 RU RU2008144290/10A patent/RU2541765C2/ru active
- 2007-04-10 JP JP2009504628A patent/JP4718634B2/ja active Active
- 2007-04-10 KR KR1020127002545A patent/KR20120028396A/ko not_active Ceased
- 2007-04-10 CA CA3081707A patent/CA3081707A1/en active Pending
- 2007-04-10 AU AU2007236199A patent/AU2007236199B2/en active Active
- 2007-04-11 AR ARP070101538A patent/AR060592A1/es active IP Right Grant
-
2008
- 2008-09-19 CR CR10301A patent/CR10301A/es not_active Application Discontinuation
- 2008-09-25 IL IL194397A patent/IL194397A/en active IP Right Grant
- 2008-09-25 NO NO20084082A patent/NO20084082L/no not_active Application Discontinuation
- 2008-10-08 ZA ZA200808597A patent/ZA200808597B/xx unknown
- 2008-10-09 EC EC2008008816A patent/ECSP088816A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009533367A5 (enExample) | ||
| TWI780083B (zh) | 抗pd-1抗體及組成物 | |
| AU2013229786B2 (en) | Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof | |
| JP6282745B2 (ja) | 修飾抗上皮成長因子受容体抗体およびその使用法 | |
| JP2009114201A5 (enExample) | ||
| CN117222663A (zh) | 使用结合nkg2d、cd16和肿瘤相关抗原的多特异性结合蛋白治疗癌症的方法 | |
| Strohl | Structure and function of therapeutic antibodies approved by the US FDA in 2023 | |
| JP2017071606A5 (enExample) | ||
| JP2009532336A5 (enExample) | ||
| JP2014533279A5 (enExample) | ||
| JP2011507932A5 (enExample) | ||
| PT2576618T (pt) | Anticorpos contra gdf8 humano | |
| WO2017161206A1 (en) | Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use | |
| JP2019527194A5 (enExample) | ||
| JP2025069249A (ja) | 多重特異性抗体およびその使用 | |
| JP2015533781A5 (enExample) | ||
| KR20200013231A (ko) | 항암 조합 요법 | |
| CA3158579A1 (en) | Heavy chain antibodies binding to cd38 | |
| JP2018512402A5 (enExample) | ||
| JP2020527152A5 (enExample) | ||
| WO2018183366A1 (en) | Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy | |
| TW202124432A (zh) | 使用pd-1軸抑制劑及抗骨膜蛋白抗體治療癌症之方法 | |
| US20250257141A1 (en) | Combination therapy for the treatment of cancer comprising a fas axis antagonist and a t-reg cell depleting agent antagonist | |
| JP7668943B2 (ja) | 多重特異性抗体およびその使用 | |
| US20220218838A1 (en) | Adc for a treatment concomitant with or subsequent to docetaxel |